Influenza Antiviral Use in Hospitalized Children Before and During the COVID-19 Pandemic
Influenza antiviral use in children hospitalized with influenza remained suboptimal following the COVID-19 pandemic. Our study highlights the need to improve antiviral use in children hospitalized with influenza.
Authors
- Michaels Mg
- John A. Williams
- J Amarin
- James W. Antoon (ORCID: https://orcid.org/0000-0001-6188-2658)
- Szilagyi Pg
- Olla Hamdan
- Samantha M. Olson
- Leila C. Sahni
- Tess Stopczynski
- Ariana P. Toepfer
- Jennifer E. Schuster
- Heidi L. Moline
- Elizabeth P. Schlaudecker
- Eileen J. Klein
- Rangaraj Selvarangan
- Mary Allen Staat
- Laura S. Stewart
- Geoffrey A. Weinberg
- James D. Chappell
- Julie A. Boom
- Andrew J. Spieker
- Natasha B. Halasa
- Janet A. Englund
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- University of Wisconsin–Madison (US)
- University of California, Los Angeles (US)
- National Center for Immunization and Respiratory Diseases (US)
- Seattle Children's Hospital (US)
- Golisano Children's Hospital (US)
- Children's Hospital of Pittsburgh (US)
- Texas Children's Hospital (US)
- Wisconsin Division of Public Health (US)
- Mercy Hospital (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- PEDIATRICS
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1542/peds.2025-071898
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00